Next Generation News and Research

RSS

Researchers engineer a tool to dismantle cancer's RNA-built growth hubs

In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form-but instead of fueling progress, they supercharge disease. That's what researchers at the Texas A&M University Health Science Center (Texas A&M Health) have discovered inside the cells of a rare and aggressive kidney cancer.

21 Oct 2025

Can fitness apps and wearables make children healthier? This study says yes - partly

Digital health tools such as apps, wearables, and web platforms can modestly improve children’s physical activity, diet, and weight outcomes. Shorter programs boost activity, while longer ones better support weight management, though effects on sleep and sedentary time remain unclear.

20 Oct 2025

Oral combination regimen improves survival in ER-positive HER-2-negative breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation selective estrogen receptor degrader and full antagonist, compared to a standard combination approach.

18 Oct 2025

New enzyme offers cleaner route to more stable diabetes and obesity drugs

Chemistry researchers at the University of Utah have uncovered an enzyme, dubbed PapB, that can "tie off" therapeutic peptides-protein-like drugs-into tight rings, a process known as macrocyclization.

16 Oct 2025

MXene materials pave the way for next-generation smart contact lenses

As wearable health technologies evolve, smart contact lenses (SCLs) are emerging as powerful platforms for non-invasive, real-time ocular diagnostics.

16 Oct 2025

Revolutionary structures show how chaperone proteins prevent diseases caused by protein misfolding

The first full-length structures of two heat shock chaperone proteins in a complex reveal the key structural region regulating their function, according to a new study from St. Jude Children's Research Hospital.

15 Oct 2025

Microarray platform could help predict immune‐mediated drug‐induced liver injury

Researchers at Cincinnati Children's Hospital Medical Center in collaboration with Roche, have developed a next-generation human liver organoid microarray platform that could help predict which drugs may cause harmful immune reactions in some people.

14 Oct 2025

Global antibiotic resistance reaches alarming levels in 2023

One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) report launched today.

14 Oct 2025

Reimagining light scattering for biotherapeutics

Wyatt Technology's DynaPro Plate Reader 4 integrates advanced light scattering techniques, optimizing workflows in biotherapeutic and nanoparticle research.

From Waters | Wyatt Technology 13 Oct 2025

Natural nasal microbes offer broad-spectrum antiviral protection

Respiratory viral diseases pose severe threats to animal health and global food security, especially in intensive pig farming systems.

10 Oct 2025

New GoT-Multi technology reveals how cancers evolve and resist treatment

A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells.

10 Oct 2025

Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology

Takara Bio USA, Inc. ("Takara Bio USA"), a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology.

9 Oct 2025

PlasmidFactory and Fraunhofer IZI join forces to advance non-viral cell and gene therapies

PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP manufacturing, aiming to accelerate non-viral cell and gene therapies for the benefit of patients.

From PlasmidFactory GmbH 9 Oct 2025

BD and Opentrons collaborate to accelerate single-cell multiomics discoveries with robotic automation

BD (Becton, Dickinson and Company), a leading global medical technology company, and Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, today announced a multi-year collaboration.

From BD (Becton, Dickinson and Company) 9 Oct 2025

Discovery of vascular-associated fibroblastic cells opens new path for diabetes treatment

Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks the cells that produce insulin-a critical hormone that regulates blood sugar in the body.

8 Oct 2025

Nanomedicine emerges as a key tool to boost cancer immunotherapy

Scientists at the Fralin Biomedical Research Institute at VTC and their collaborators are exploring emerging trends in cancer immunotherapy, with back-to-back review articles published in Nature Cancer and Trends in Cancer that look at how nanotechnology could reprogram the immune system and help overcome tumors' defenses.

8 Oct 2025

Harmful DNA changes in the sperm found to rise sharply with age

Harmful genetic changes in sperm become substantially more common as men age because some are actively favored during sperm production, new research has revealed.

8 Oct 2025

Survey finds widespread gaps in safe tissue containment during laparoscopic gynecologic surgery

A new national survey of first-year fellows in minimally invasive gynecologic surgery (FMIGS) has revealed significant gaps in the use of FDA-cleared containment systems during laparoscopic hysterectomy and myomectomy.

8 Oct 2025

Ireland launches next phase of national precision oncology program

Today (8th October), Ireland's Minister for Further and Higher Education, Research, Innovation and Science, James Lawless TD, launched Phase 2 of the country's leading and largest ever cancer research program, Precision Oncology Ireland (POI).

8 Oct 2025

Aptamer expands into targeted radiopharmaceuticals with major top 3 pharma contract

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, has announced a significant development contract with a top 3 global pharmaceutical company to engineer Optimer® binders as targeted radiopharmaceuticals for potential therapeutic applications.

8 Oct 2025

Next Generation News and Research

Researchers engineer a tool to dismantle cancer's RNA-built growth hubs

Can fitness apps and wearables make children healthier? This study says yes - partly

Oral combination regimen improves survival in ER-positive HER-2-negative breast cancer

New enzyme offers cleaner route to more stable diabetes and obesity drugs

MXene materials pave the way for next-generation smart contact lenses

Revolutionary structures show how chaperone proteins prevent diseases caused by protein misfolding

Microarray platform could help predict immune‐mediated drug‐induced liver injury

Global antibiotic resistance reaches alarming levels in 2023

Reimagining light scattering for biotherapeutics

Natural nasal microbes offer broad-spectrum antiviral protection

New GoT-Multi technology reveals how cancers evolve and resist treatment

Takara Bio USA, Inc. announces a series of updates to its spatial biology product portfolio, extending its innovation with a new class of spatial technology

PlasmidFactory and Fraunhofer IZI join forces to advance non-viral cell and gene therapies

BD and Opentrons collaborate to accelerate single-cell multiomics discoveries with robotic automation

Discovery of vascular-associated fibroblastic cells opens new path for diabetes treatment

Nanomedicine emerges as a key tool to boost cancer immunotherapy

Harmful DNA changes in the sperm found to rise sharply with age

Survey finds widespread gaps in safe tissue containment during laparoscopic gynecologic surgery

Ireland launches next phase of national precision oncology program

Aptamer expands into targeted radiopharmaceuticals with major top 3 pharma contract

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News